An advisory panel for the Food and Drug Administration concluded Wednesday that Switzerland.-based Novartis AG's version of Amgen's arthritis drug Enbrel should be approved, according to Reuters.
Supply Chain
As the costs of EpiPens and other auto injectors soar, many EMTs and some consumers resort to traditional syringes as a cheaper alternative, according to PBS Newshour reports.
Premier, a healthcare purchasing organization based in Charlotte, N.C., expanded its partnership with the University of Texas System.
California health advocates proposed legislation that would require drugmakers to give advance notice before raising the cost of drugs, according to NBCNews.
Future Market Insights released new data on wearable medical devices this month, predicting the global market will reach $24 million in revenue by the end of 2016.
Advertisement
The Food and Drug Administration has expanded the use of Pfizer's pneumonia vaccine, allowing adults age 18 through 49 to receive the vaccine, according to Reuters.
Themis Bioscience plans to start clinical trials for its experimental Zika virus vaccine in the next 12 months, according to Reuters.
Minneapolis-based Medtronic will invest an additional $20 million in Mazor Robotics — an Israeli med-tech company that released a new robotically assisted spine surgery system on Tuesday, according to StarTribune.
An advisory panel for the Food and Drug Administration concluded Tuesday that Thousand Oaks, Calif.-based Amgen's version of AbbVie's arthritis drug Humira should be approved, according to Reuters.
GE Healthcare is marking its territory in the cell therapy market with the recent acquisition of Biosafe Group SA, a supplier of cell processing systems.